DOCSLIB.ORG

BULLETIN on NARCOTICS, Volume LVII, Nos. 1 and 2, 2005

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
BULLETIN on NARCOTICS, Volume LVII, Nos. 1 and 2, 2005 Volume LVII, Nos. 1 and 2, 2005 Science in drug control: the role of laboratory and scientific expertise UNITED NATIONS OFFICE ON DRUGS AND CRIME Vienna BULLETIN ON NARCOTICS Volume LVII, Nos. 1 and 2, 2005 Science in drug control: the role of laboratory and scientific expertise UNITED NATIONS New York, 2007 UNITED NATIONS PUBLICATION Sales No. E.07.XI.3 ISBN 978-92-1-148221-8 ISSN 0007-523X Sandeep Chawla, Editor, Suzanne Kunnen, Editorial Assistant United Nations Office on Drugs and Crime Vienna International Centre P.O. Box 500 1400 Vienna, Austria Telephone: (+43-1) 26060-5799 Fax: (+43-1) 26060-5866 The Bulletin on Narcotics is available on the World Wide Web at http://www.unodc.org/unodc/en/ bulletin_on_narcotics.html. It should be noted that, although the year 2005 appears on its cover, the present issue was published only in 2007. Views expressed in signed articles published in the Bulletin are those of the authors and do not necessarily reflect those of the United Nations Secretariat. The designations employed and the presentation of the material in this publi- cation do not imply the expression of any opinion whatsoever on the part of the Secretariat concerning the legal status of any country, territory, city or area, or its authorities, or concerning the delimitation of any frontiers or boundaries. Material published in the Bulletin is the property of the United Nations and enjoys copyright protection in accordance with the provisions of Protocol 2 annexed to the Universal Copyright Convention concerning the application of that Convention to the works of certain international organizations. PREFACE The Bulletin on Narcotics is a United Nations journal that has been in continuous publication since 1949. It is printed in all six official languages of the United Nations: Arabic, Chinese, English, French, Russian and Spanish. The Bulletin provides information on developments in drug control at the local, national, regional and international levels that can be of benefit to the international community. The present double issue of the Bulletin (vol. LVII, Nos. 1 and 2) is the first to provide a comprehensive overview of the crucial role of scientific and laboratory expertise in drug control. It should be noted that for the sake of continuity, 2005 is given as the year of publication of this issue. Thanks go to Barbara Remberg of the Laboratory and Scientific Section of the United Nations Office on Drugs and Crime for the preparation of this issue. iii EDITORIAL POLICY AND GUIDELINES FOR PUBLICATION Individuals and organizations are invited by the Editor to contribute articles to the Bulletin dealing with policies, approaches, measures and developments (theoretical and/or practical) relating to various aspects of the drug control effort. Of particular interest are the results of research, studies and practical experience that would provide useful information for policymakers, practitioners and experts, as well as the public at large. All manuscripts submitted for publication in the Bulletin should constitute original and scholarly work that has not been published elsewhere or is not being submitted simultaneously for publication elsewhere. The work should be of relatively high professional calibre in order to meet the requirements of a United Nations technical publication. Contributors are kindly asked to exercise discretion in the content of manuscripts so as to exclude any critical judgement of a particular national or regional situation. The preferred mode of transmission of manuscripts is Word format. Each manuscript submitted should consist of an original hard copy and an electronic version (in Word for the text and in Excel for tables and figures) in any of the six official languages of the United Nations (Arabic, Chinese, English, French, Russian and Spanish). The manuscript should be accompanied by an abstract of approximately 200 words, a complete set of references numbered in the order of their appearance in the text and a list of key words. The manuscript should be between 10 and 20 double-spaced typewritten pages, including tables, figures and references. Tables should be self-explanatory and should supplement, not duplicate, information provided in the text. Manuscripts, together with brief curricula vitae of their authors, should be addressed to the Editor, Bulletin on Narcotics, United Nations Office on Drugs and Crime, Vienna International Centre, P.O. Box 500, 1400 Vienna, Austria. A transmittal letter should designate one author as correspondent and include his or her complete address, telephone number, fax number and e-mail address. Unpublished manuscripts will be returned to the authors; however, the United Nations cannot be held responsible for loss. iv Reprints, purchases and subscriptions All issues of the Bulletin (from vol. I, No. 1 (1949), to the present issue) are available on the home page of the United Nations Office on Drugs and Crime (http://www.unodc.org/unodc/en/bulletin_on_narcotics.html). The following special issues of the Bulletin are also available as United Nations pub- lications: 1993 Policy issues relating to drug abuse and the human immunodeficiency virus (HIV) (vol. XLV, No. 1) Drug testing in the workplace (vol. XLV, No. 2) 1994 The family and drug abuse (vol. XLVI, No. 1) General issue on drug abuse (vol. XLVI, No. 2) 1995 Special issue on gender and drug abuse (vol. XLVII, Nos. 1 and 2) 1996 Special issue on rapid assessment of drug abuse (vol. XLVIII, Nos. 1 and 2) 1997 and 1998 Double issue on cannabis: recent developments (vol. XLIX, Nos. 1 and 2, and vol. L, Nos. 1 and 2) 1999 Occasional papers (vol. LI, Nos. 1 and 2) 2000 Economic and social costs of substance abuse (vol. LII, Nos. 1 and 2) 2001 Dynamic drug policy: understanding and controlling drug epidemics (vol. LIII, Nos. 1 and 2) 2002 The science of drug abuse epidemiology (vol. LIV, Nos. 1 and 2) 2003 The practice of drug abuse epidemiology (vol. LV, Nos. 1 and 2) 2004 Illicit drug markets (vol. LVI, Nos. 1 and 2) v Requests for permission to reprint signed material should be addressed to the Secretary of the Publications Board, United Nations, New York, New York 10017, United States of America. Correspondence regarding the purchase of copies of and subscriptions to the Bulletin should be addressed as follows: For Asia, North America, Oceania and South America: The Chief Sales and Marketing Office in New York United Nations Publications United Nations Headquarters New York, NY 10017 United States of America For Africa, Europe and the Middle East: The Chief Sales and Marketing Office in Geneva United Nations Publications United Nations Office at Geneva Palais des Nations CH-1211 Geneva 10 Switzerland vi CONTENTS Page Preface . iii Editorial: science in drug control by B. Remberg and A. H. Stead . 1 I. Drug production Documentation of a heroin manufacturing process in Afghanistan by U. Zerell, B. Ahrens and P. Gerz . 11 Impurity profiling/comparative analyses of samples of 1-phenyl-2-propanone by W. Krawczyk, D. Dudek, T. Kunda and I. Perkowska. 33 Investigation of the origin of ephedrine and methamphetamine by stable isotope ratio mass spectrometry: a Japanese experience by Y. Makino, Y. Urano and T. Nagano . 63 Cultivation of Cannabis sativa L. in northern Morocco by H. Stambouli, A. El Bouri, M. A. Bellimam, T. Bouayoun and N. El Karni . 79 II. Drug trafficking and interdiction Establishment of an operational system for drug profiling: a Swiss experience by S. Ioset, P. Esseiva, O. Ribaux, C. Weyermann, F. Anglada, S. Lociciro, P. Hayoz, I. Baer, L. Gasté, A.-L. Terrettaz-Zufferey, C. Delaporte and P. Margot . 121 Drug profiling: a new scientific contribution to law enforcement operations in Viet Nam by H. M. Hung, N. D. Tien and N. X. Truong . 149 Residual solvents in methylenedioxymethamphetamine tablets as a source of strategic information and as a tool for comparative analysis: the development and application of a static headspace gas chromatography/mass spectrometry method by H. A. A. H. Visser, M. Visser-van Leeuwen and H. Huizer . 167 vii Page Determination of inorganic elements in poppy straw by scanning electron microscopy with energy dispersive spectrometry as a means of ascertaining origin by E. Çopur, N. G. Gö4ger, B. Sener¸ and T. Orbey . 183 III. Drug abuse On-site drug testing by O. H. Drummer . 205 Drugs and driving: the Finnish perspective by P. Lillsunde and T. Gunnar . 213 Role of drug testing as an early warning programme: the experience of the Republic of Korea by Heesun Chung . 231 Psychoactive plant abuse: the identification of mitragynine in ketum and in ketum preparations by K. B. Chan, C. Pakiam and Rusyidah A. Rahim . 249 IV. Quality management in laboratories Quality management systems and the admissibility of scientific evidence: the Costa Rican experience by M. Salas and D. Gómez . 259 viii Editorial: science in drug control B. Remberg and A. H. Stead Laboratory and Scientific Section, Policy Analysis and Research Branch, Division for Policy Analysis and Public Affairs, United Nations Office on Drugs and Crime Science is not obvious, nor is it a “fact factory” producing comprehensive information. It is a systematic approach to knowledge about the material world that progresses by ruling out what is not true. Contrary to the way most people think of science, its purpose is not to amass evidence in support of every critical point in an argument in order to prove truth. In some ways, the accumulation of specific facts is a by-product of science. The true objective of the scientific enter- prise is understanding, which comes as much from the intellect as from experience. Tee L. Guidotti, Science on the Witness Stand Fifty-five years after the first publication was issued as part of a United Nations- led international collaborative scientific research programme in the field of drug control,* the present special issue of the Bulletin on Narcotics compiles 13 articles from scientists from around the world, on priority subjects of a scientific and technical nature.
Load more

Recommended publications
  • Legendary Archipelago Excursions
    EXCURSIONS LEGENDARY ARCHIPELAGO - 7 NIGHT 2021 Why book a Celestyal excursion Although we say it ourselves, the destinations on a Celestyal cruise are rather special. Call us biased but we think they are among the most exciting, beautiful, historic, iconic and evocative in the world. So a very warm welcome to our Legendary Archipelago excursions. Joining us on the seven night itinerary, you will be immersed in the most fabulous experiences living and breathing the myths and legends of Ancient Greece, discovering long past civilisations, following in the footsteps of great figures from history and seeing some of the most wondrous scenery on the planet. From classical Athens to beautiful Thessaloniki, Mykonos, Santorini, Rhodes, Limassol and scenic Agios Nikolaos. You will be amazed at what we can see and do in a week. We like to feel that we are taking you on your very own Greek Odyssey across the Aegean. And nobody knows the Eastern Mediterranean and the Greek Islands better than we do. You can be sure of that. Whether the history and culture is your thing or you are more about the outstanding natural beauty, the magnificent beaches or indeed the whole experience wrapped up together, we have something to match. Our specially designed excursions are central to your Celestyal experience with our expert guides taking you step by step through your voyage of discovery and really bringing our destinations alive. Sometimes in history it’s not easy to work out where facts end and legends begin. So please fire up your imagination and join us to find out.
    [Show full text]
  • Precursors and Chemicals Frequently Used in the Illicit Manufacture of Narcotic Drugs and Psychotropic Substances 2017
    INTERNATIONAL NARCOTICS CONTROL BOARD Precursors and chemicals frequently used in the illicit manufacture of narcotic drugs and psychotropic substances 2017 EMBARGO Observe release date: Not to be published or broadcast before Thursday, 1 March 2018, at 1100 hours (CET) UNITED NATIONS CAUTION Reports published by the International Narcotics Control Board in 2017 The Report of the International Narcotics Control Board for 2017 (E/INCB/2017/1) is supplemented by the following reports: Narcotic Drugs: Estimated World Requirements for 2018—Statistics for 2016 (E/INCB/2017/2) Psychotropic Substances: Statistics for 2016—Assessments of Annual Medical and Scientific Requirements for Substances in Schedules II, III and IV of the Convention on Psychotropic Substances of 1971 (E/INCB/2017/3) Precursors and Chemicals Frequently Used in the Illicit Manufacture of Narcotic Drugs and Psychotropic Substances: Report of the International Narcotics Control Board for 2017 on the Implementation of Article 12 of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988 (E/INCB/2017/4) The updated lists of substances under international control, comprising narcotic drugs, psychotropic substances and substances frequently used in the illicit manufacture of narcotic drugs and psychotropic substances, are contained in the latest editions of the annexes to the statistical forms (“Yellow List”, “Green List” and “Red List”), which are also issued by the Board. Contacting the International Narcotics Control Board The secretariat of the Board may be reached at the following address: Vienna International Centre Room E-1339 P.O. Box 500 1400 Vienna Austria In addition, the following may be used to contact the secretariat: Telephone: (+43-1) 26060 Fax: (+43-1) 26060-5867 or 26060-5868 Email: [email protected] The text of the present report is also available on the website of the Board (www.incb.org).
    [Show full text]
  • COMBINED LIST of Particularly Hazardous Substances
    COMBINED LIST of Particularly Hazardous Substances revised 2/4/2021 IARC list 1 are Carcinogenic to humans list compiled by Hector Acuna, UCSB IARC list Group 2A Probably carcinogenic to humans IARC list Group 2B Possibly carcinogenic to humans If any of the chemicals listed below are used in your research then complete a Standard Operating Procedure (SOP) for the product as described in the Chemical Hygiene Plan. Prop 65 known to cause cancer or reproductive toxicity Material(s) not on the list does not preclude one from completing an SOP. Other extremely toxic chemicals KNOWN Carcinogens from National Toxicology Program (NTP) or other high hazards will require the development of an SOP. Red= added in 2020 or status change Reasonably Anticipated NTP EPA Haz list COMBINED LIST of Particularly Hazardous Substances CAS Source from where the material is listed. 6,9-Methano-2,4,3-benzodioxathiepin, 6,7,8,9,10,10- hexachloro-1,5,5a,6,9,9a-hexahydro-, 3-oxide Acutely Toxic Methanimidamide, N,N-dimethyl-N'-[2-methyl-4-[[(methylamino)carbonyl]oxy]phenyl]- Acutely Toxic 1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea (Methyl-CCNU) Prop 65 KNOWN Carcinogens NTP 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) IARC list Group 2A Reasonably Anticipated NTP 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) (Lomustine) Prop 65 1-(o-Chlorophenyl)thiourea Acutely Toxic 1,1,1,2-Tetrachloroethane IARC list Group 2B 1,1,2,2-Tetrachloroethane Prop 65 IARC list Group 2B 1,1-Dichloro-2,2-bis(p -chloropheny)ethylene (DDE) Prop 65 1,1-Dichloroethane
    [Show full text]
  • "Official Gazette of RM", No. 28/04 and 37/07), the Government of the Republic of Montenegro, at Its Meeting Held on ______2007, Enacted This
    In accordance with Article 6 paragraph 3 of the FT Law ("Official Gazette of RM", No. 28/04 and 37/07), the Government of the Republic of Montenegro, at its meeting held on ____________ 2007, enacted this DECISION ON CONTROL LIST FOR EXPORT, IMPORT AND TRANSIT OF GOODS Article 1 The goods that are being exported, imported and goods in transit procedure, shall be classified into the forms of export, import and transit, specifically: free export, import and transit and export, import and transit based on a license. The goods referred to in paragraph 1 of this Article were identified in the Control List for Export, Import and Transit of Goods that has been printed together with this Decision and constitutes an integral part hereof (Exhibit 1). Article 2 In the Control List, the goods for which export, import and transit is based on a license, were designated by the abbreviation: “D”, and automatic license were designated by abbreviation “AD”. The goods for which export, import and transit is based on a license designated by the abbreviation “D” and specific number, license is issued by following state authorities: - D1: the goods for which export, import and transit is based on a license issued by the state authority competent for protection of human health - D2: the goods for which export, import and transit is based on a license issued by the state authority competent for animal and plant health protection, if goods are imported, exported or in transit for veterinary or phyto-sanitary purposes - D3: the goods for which export, import and transit is based on a license issued by the state authority competent for environment protection - D4: the goods for which export, import and transit is based on a license issued by the state authority competent for culture.
    [Show full text]
  • Celestyal Cruises
    EXCURSIONS LEGENDARY ARCHIPELAGO - 7 NIGHT 2021 Why book a Celestyal excursion Although we say it ourselves, the destinations on a Celestyal cruise are rather special. Call us biased but we think they are among the most exciting, beautiful, historic, iconic and evocative in the world. So a very warm welcome to our Legendary Archipelago excursions. Joining us on the seven night itinerary, you will be immersed in the most fabulous experiences living and breathing the myths and legends of Ancient Greece, discovering long past civilisations, following in the footsteps of great figures from history and seeing some of the most wondrous scenery on the planet. From classical Athens to beautiful Thessaloniki, Mykonos, Santorini, Rhodes, Limassol and scenic Agios Nikolaos. You will be amazed at what we can see and do in a week. We like to feel that we are taking you on your very own Greek Odyssey across the Aegean. And nobody knows the Eastern Mediterranean and the Greek Islands better than we do. You can be sure of that. Whether the history and culture is your thing or you are more about the outstanding natural beauty, the magnificent beaches or indeed the whole experience wrapped up together, we have something to match. Our specially designed excursions are central to your Celestyal experience with our expert guides taking you step by step through your voyage of discovery and really bringing our destinations alive. Sometimes in history it’s not easy to work out where facts end and legends begin. So please fire up your imagination and join us to find out.
    [Show full text]
  • A Study of the Intermediate Steps in the Preparation of Alkylphenylbarbituric Acids James Edward Doyle University of Massachusetts Amherst
    University of Massachusetts Amherst ScholarWorks@UMass Amherst Masters Theses 1911 - February 2014 1933 A study of the intermediate steps in the preparation of alkylphenylbarbituric acids James Edward Doyle University of Massachusetts Amherst Follow this and additional works at: https://scholarworks.umass.edu/theses Doyle, James Edward, "A study of the intermediate steps in the preparation of alkylphenylbarbituric acids" (1933). Masters Theses 1911 - February 2014. 1468. Retrieved from https://scholarworks.umass.edu/theses/1468 This thesis is brought to you for free and open access by ScholarWorks@UMass Amherst. It has been accepted for inclusion in Masters Theses 1911 - February 2014 by an authorized administrator of ScholarWorks@UMass Amherst. For more information, please contact [email protected]. A STUDY OF THE INTERMEDIATE STEPS IN THE PREPARATION OF ALKYLPHENYLBARBITURIC ACIDS JAMES EDWARD DOYLE Thesis submitted for the degree of Master of Science MASSACHUSETTS STATE COLLEGE June 1933 TABLE OF CONTENTS Page I. INTRODUCTION 1 II. THEORY AND REVIEW OF LITERATURE 2 A. Abstracts of Patents 2 B. Previous Work on Luminal 5 C. Reactions 9 D. Previous Work on Cyanophenylacetic Acid ll*. E f Previous Work on 5»5-Isopropylphenyl- barbituric Acid 17 III. EXPERIMENTAL WORK 19 A. Preparation of Luminal 19 1. Benzyl Cyanide 21 2. Ethyl Cyanophenylacetate 22 3. Ethyl Cyanoethylphenylacetate 2l\. 5,5-Sthylphenyl-^-iminobarbituric Acid25 5. 5,5-Ethylphenylbarbituric Acid 27 B. Preparation of Ethyl oc ,-f-Dicyano-oc ,f« diphenylacetoacetate 27 1. Ethyl oc ,-Y-Dicyano-cc ,v -diphenyl- acetoacetate 29 2. Ethyl y-Cyano-oc ,Y -diphenylacetoacetate 3 2 C. Preparation of Cyanophenylacetic Acid 3k 1.
    [Show full text]
  • Benzyl Chlorid Final
    Survey of benzyl chloride (CAS no. 100-44-7) Part of the LOUS-review [Series Title and year] Consultation draft Title: Editing: Survey of benzyl chloride (CAS no. 100-44-7) Pia Brunn Poulsen, FORCE Technology Maria Strandesen, FORCE Technology Anders Schmidt, FORCE Technology Published by: Photography: The Danish Environmental Protection Agency [Name] Strandgade 29 1401 Copenhagen K Denmark Illustration: www.mst.dk/english [Name] Year: Map: [xxxx] [Name] ISBN no. [xxxxxx] Disclaimer: When the occasion arises, the Danish Environmental Protection Agency will publish reports and papers concerning research and development projects within the environmental sector, financed by study grants provided by the Danish Environmental Protection Agency. It should be noted that such publications do not necessarily reflect the position or opinion of the Danish Environmental Protection Agency. However, publication does indicate that, in the opinion of the Danish Environmental Protection Agency, the content represents an important contribution to the debate surrounding Danish environmental policy. While the information provided in this report is believed to be accurate, The Danish Environmental Protection Agency disclaims any responsibility for possible inaccuracies or omissions and consequences that may flow from them. Neither the Danish Environmental Protection Agency nor FORCE Technology or any individual involved in the preparation of this publication shall be liable for any injury, loss, damage or prejudice of any kind that may be caused by persons who have acted based on their understanding of the information contained in this publication. Sources must be acknowledged. 2 Survey of benzyl chloride (CAS no. 100-44-7) Contents Preface ...................................................................................................................... 6 Summary and conclusions ......................................................................................... 8 Sammenfatning og konklusion ...............................................................................
    [Show full text]
  • Safe Handling and Disposal of Chemicals Used in the Illicit Manufacture of Drugs
    Vienna International Centre, PO Box 500, 1400 Vienna, Austria Tel.: (+43-1) 26060-0, Fax: (+43-1) 26060-5866, www.unodc.org Guidelines for the Safe handling and disposal of chemicals used in the illicit manufacture of drugs United Nations publication USD 26 Printed in Austria ISBN 978-92-1-148266-9 Sales No. E.11.XI.14 ST/NAR/36/Rev.1 V.11-83777—September*1183777* 2011—300 Guidelines for the Safe handling and disposal of chemicals used in the illlicit manufacture of drugs UNITED NATIONS New York, 2011 Symbols of United Nations documents are composed of letters combined with figures. Mention of such symbols indicates a reference to a United Nations document. ST/NAR/36/Rev.1 UNITED NATIONS PUBLICATION Sales No. E.11.XI.14 ISBN 978-92-1-148266-9 eISBN 978-92-1-055160-1 © United Nations, September 2011. All rights reserved. The designations employed and the presentation of material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal status of any country, territory, city or area, or of its authorities, or concerning the delimitation of its frontiers or boundaries. Requests for permission to reproduce this work are welcomed and should be sent to the Secretary of the Publications Board, United Nations Headquarters, New York, N.Y. 10017, U.S.A. or also see the website of the Board: https://unp.un.org/Rights.aspx. Governments and their institutions may reproduce this work without prior authoriza- tion but are requested to mention the source and inform the United Nations of such reproduction.
    [Show full text]
  • Toxic, and Comatose-Fatal Blood-Plasma Concentrations (Mg/L) in Man
    Therapeutic (“normal”), toxic, and comatose-fatal blood-plasma concentrations (mg/L) in man Substance Blood-plasma concentration (mg/L) t½ (h) Ref. therapeutic (“normal”) toxic (from) comatose-fatal (from) Abacavir (ABC) 0.9-3.9308 appr. 1.5 [1,2] Acamprosate appr. 0.25-0.7231 1311 13-20232 [3], [4], [5] Acebutolol1 0.2-2 (0.5-1.26)1 15-20 3-11 [6], [7], [8] Acecainide see (N-Acetyl-) Procainamide Acecarbromal(um) 10-20 (sum) 25-30 Acemetacin see Indomet(h)acin Acenocoumarol 0.03-0.1197 0.1-0.15 3-11 [9], [3], [10], [11] Acetaldehyde 0-30 100-125 [10], [11] Acetaminophen see Paracetamol Acetazolamide (4-) 10-20267 25-30 2-6 (-13) [3], [12], [13], [14], [11] Acetohexamide 20-70 500 1.3 [15] Acetone (2-) 5-20 100-400; 20008 550 (6-)8-31 [11], [16], [17] Acetonitrile 0.77 32 [11] Acetyldigoxin 0.0005-0.00083 0.0025-0.003 0.005 40-70 [18], [19], [20], [21], [22], [23], [24], [25], [26], [27] 1 Substance Blood-plasma concentration (mg/L) t½ (h) Ref. therapeutic (“normal”) toxic (from) comatose-fatal (from) Acetylsalicylic acid (ASS, ASA) 20-2002 300-3502 (400-) 5002 3-202; 37 [28], [29], [30], [31], [32], [33], [34] Acitretin appr. 0.01-0.05112 2-46 [35], [36] Acrivastine -0.07 1-2 [8] Acyclovir 0.4-1.5203 2-583 [37], [3], [38], [39], [10] Adalimumab (TNF-antibody) appr. 5-9 146 [40] Adipiodone(-meglumine) 850-1200 0.5 [41] Äthanol see Ethanol -139 Agomelatine 0.007-0.3310 0.6311 1-2 [4] Ajmaline (0.1-) 0.53-2.21 (?) 5.58 1.3-1.6, 5-6 [3], [42] Albendazole 0.5-1.592 8-992 [43], [44], [45], [46] Albuterol see Salbutamol Alcuronium 0.3-3353 3.3±1.3 [47] Aldrin -0.0015 0.0035 50-1676 (as dieldrin) [11], [48] Alendronate (Alendronic acid) < 0.005322 -6 [49], [50], [51] Alfentanil 0.03-0.64 0.6-2.396 [52], [53], [54], [55] Alfuzosine 0.003-0.06 3-9 [8] 2 Substance Blood-plasma concentration (mg/L) t½ (h) Ref.
    [Show full text]
  • Marrakesh Agreement Establishing the World Trade Organization
    No. 31874 Multilateral Marrakesh Agreement establishing the World Trade Organ ization (with final act, annexes and protocol). Concluded at Marrakesh on 15 April 1994 Authentic texts: English, French and Spanish. Registered by the Director-General of the World Trade Organization, acting on behalf of the Parties, on 1 June 1995. Multilat ral Accord de Marrakech instituant l©Organisation mondiale du commerce (avec acte final, annexes et protocole). Conclu Marrakech le 15 avril 1994 Textes authentiques : anglais, français et espagnol. Enregistré par le Directeur général de l'Organisation mondiale du com merce, agissant au nom des Parties, le 1er juin 1995. Vol. 1867, 1-31874 4_________United Nations — Treaty Series • Nations Unies — Recueil des Traités 1995 Table of contents Table des matières Indice [Volume 1867] FINAL ACT EMBODYING THE RESULTS OF THE URUGUAY ROUND OF MULTILATERAL TRADE NEGOTIATIONS ACTE FINAL REPRENANT LES RESULTATS DES NEGOCIATIONS COMMERCIALES MULTILATERALES DU CYCLE D©URUGUAY ACTA FINAL EN QUE SE INCORPOR N LOS RESULTADOS DE LA RONDA URUGUAY DE NEGOCIACIONES COMERCIALES MULTILATERALES SIGNATURES - SIGNATURES - FIRMAS MINISTERIAL DECISIONS, DECLARATIONS AND UNDERSTANDING DECISIONS, DECLARATIONS ET MEMORANDUM D©ACCORD MINISTERIELS DECISIONES, DECLARACIONES Y ENTEND MIENTO MINISTERIALES MARRAKESH AGREEMENT ESTABLISHING THE WORLD TRADE ORGANIZATION ACCORD DE MARRAKECH INSTITUANT L©ORGANISATION MONDIALE DU COMMERCE ACUERDO DE MARRAKECH POR EL QUE SE ESTABLECE LA ORGANIZACI N MUND1AL DEL COMERCIO ANNEX 1 ANNEXE 1 ANEXO 1 ANNEX
    [Show full text]
  • Crete (Chapter)
    Greek Islands Crete (Chapter) Edition 7th Edition, March 2012 Pages 56 Page Range 256-311 PDF Coverage includes: Central Crete, Iraklio, Cretaquarium, Knossos, Arhanes, Zaros, Matala, Rethymno, Moni Arkadiou, Anogia, Mt Psiloritis, Spili, Plakias & around, Beaches Between Plakias & Agia Galini, Agia Galini, Western Crete, Hania & around, Samaria Gorge, Hora Sfakion & around, Frangokastello, Anopoli & Inner Sfakia, Sougia, Paleohora, Elafonisi, Gavdos Island, Kissamos-Kastelli & around, Eastern Crete, Lasithi Plateau, Agios Nikolaos & around, Mohlos, Sitia & around, Kato Zakros & Ancient Zakros, and Ierapetra & around. Useful Links: Having trouble viewing your file? Head to Lonely Planet Troubleshooting. Need more assistance? Head to the Help and Support page. Want to find more chapters? Head back to the Lonely Planet Shop. Want to hear fellow travellers’ tips and experiences? Lonely Planet’s Thorntree Community is waiting for you! © Lonely Planet Publications Pty Ltd. To make it easier for you to use, access to this chapter is not digitally restricted. In return, we think it’s fair to ask you to use it for personal, non-commercial purposes only. In other words, please don’t upload this chapter to a peer-to-peer site, mass email it to everyone you know, or resell it. See the terms and conditions on our site for a longer way of saying the above - ‘Do the right thing with our content. ©Lonely Planet Publications Pty Ltd Crete Why Go? Iraklio ............................ 261 Crete (Κρήτη) is in many respects the culmination of the Knossos ........................268 Greek experience. Nature here has been as prolifi c as Picas- Rethymno ..................... 274 so in his prime, creating a dramatic quilt of big-shouldered Anogia .........................
    [Show full text]
  • Morocco and Cannabis Reduction, Containment Or Acceptance
    DRUG POLICY BRIEFING | 49 | March 2017 Morocco and Cannabis Reduction, containment or acceptance Tom Blickman1 KEY POINTS • Morocco continues to be the world’s largest producer of cannabis resin (hashish). Over the past 50 years, the Moroccan cannabis growers shown a remarkable resilience to government attempts to eradicate or reduce cannabis cultivation as well as a noteworthy ability to adapt to changing international market conditions. • Since Morocco’s independence the government has practiced a policy of containment regarding cannabis cultivation, allowing no new areas but tacitly allowing those already in production to be maintained. • The rapid increase in illicit cannabis cultivation in the Rif during the last decades, as well as poor soil conservation practices, have taken a heavy toll on the Rif’s already threatened forests and fragile ecosystems. • The unregulated cannabis market in Morocco has negative social consequences. Some 48,000 growers have arrest warrants hanging over their heads, which is a source of corruption and repression. An amnesty and decriminalization could be effective measures to diminish negative social consequences and open the debate about regulation. • Cannabis farmers in Morocco should have access to emerging legally regulated cannabis markets that are gaining ground worldwide. The challenge is to find a sustainable development model that includes cannabis cultivation in Morocco, instead of excluding cannabis and ignoring the realities of more than 50 years of failed attempts to eradicate the only viable
    [Show full text]